The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
IQ Healthy Hearts ETF HART
Morningstar’s Analysis HART
Will HART outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Apple Inc | 5.56 | 477,173 | Technology |
UnitedHealth Group Inc | 5.56 | 476,847 | Healthcare |
Johnson & Johnson | 5.35 | 459,125 | Healthcare |
Novartis AG Registered Shares | 5.25 | 449,920 | Healthcare |
Pfizer Inc | 5.18 | 444,189 | Healthcare |
Abbott Laboratories | 5.10 | 437,403 | Healthcare |
Eli Lilly and Co | 4.92 | 422,092 | Healthcare |
AstraZeneca PLC | 4.92 | 422,079 | Healthcare |
Alphabet Inc Class A | 4.77 | 409,167 | Communication Services |
Novo Nordisk A/S Class B | 4.67 | 400,896 | Healthcare |